Michael Jones, | |
8900 Van Wyck Expy, Jamaica, NY 11418-2897 | |
(718) 206-7001 | |
Not Available |
Full Name | Michael Jones |
---|---|
Gender | Male |
Speciality | Plastic Surgery |
Location | 8900 Van Wyck Expy, Jamaica, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134297484 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Michael Jones, 80 Marcus Dr, Provider Enrollment, Melville, NY 11747-4230 Ph: () - | Michael Jones, 8900 Van Wyck Expy, Jamaica, NY 11418-2897 Ph: (718) 206-7001 |
News Archive
Developer of ground-breaking ozone-based hospital sterilization technology - AscepticSure(TM), Medizone announced today that its common stock has begun trading on the OTC Bulletin Board (OTC Bulletin Board: MZEI). The company's common stock was previously quoted on the Pink Sheets.
UT Southwestern Medical Center neurology researchers have identified an important cell signaling mechanism that plays an important role in brain cancer and may provide a new therapeutic target.
Too many women worldwide – particularly the poorest women – continue to die from cervical cancer; a disease which is both preventable and treatable.
University of British Columbia researchers have discovered the molecular pathway that enables receptors inside immune cells to find, and flag, fragments of pathogens trying to invade a host.
Karius, a life sciences company transforming infectious disease diagnostics with genomics and data through the innovative use of next-generation sequencing to analyze microbial cell-free DNA, announced today the positive results of a clinical study using blood samples from patients with confirmed invasive fungal infections.
› Verified 7 days ago